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Some Commonly Used Brominated Flame Retardants
Cause Ca2+-ATPase Inhibition, Beta-Amyloid Peptide
Release and Apoptosis in SH-SY5Y Neuronal Cells
Fawaz Al-Mousa, Francesco Michelangeli*
School of Biosciences, University Of Birmingham, Edgbaston, Birmingham, United Kingdom
Abstract
Brominated flame retardants (BFRs) are chemicals commonly used to reduce the flammability of consumer products and are
considered pollutants since they have become widely dispersed throughout the environment and have also been shown to
bio-accumulate within animals and man. This study investigated the cytotoxicity of some of the most commonly used
groups of BFRs on SH-SY5Y human neuroblastoma cells. The results showed that of the BFRs tested, hexabromocyclo-
dodecane (HBCD), tetrabromobisphenol-A (TBBPA) and decabromodiphenyl ether (DBPE), all are cytotoxic at low
micromolar concentrations (LC50 being 2.760.7mM, 1564mM and 2867mM, respectively). They induced cell death, at least in
part, by apoptosis through activation of caspases. They also increased intracellular [Ca2+] levels and reactive-oxygen-species
within these neuronal cells. Furthermore, these BFRs also caused rapid depolarization of the mitochondria and cytochrome c
release in these neuronal cells. Elevated intracellular [Ca2+] levels appear to occur through a mechanism involving
microsomal Ca2+-ATPase inhibition and this maybe responsible for Ca2+-induced mitochondrial dysfunction. In addition, mM
levels of these BFRs caused b-amyloid peptide (Ab-42) processing and release from these cells with a few hours of exposure.
These results therefore shows that these pollutants are both neurotoxic and amyloidogenic in-vitro.
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Introduction
Brominated flame retardants (BFRs) are chemicals commonly
used to reduce the flammability of a variety of consumer products
such as electrical goods and foam furnishings [1]. These chemicals
are widely dispersed and slowly degraded within the environment
and are therefore referred to as persistent organic pollutants
(POPs) [1,2]. Several studies have suggested that some BFRs such
as the polybrominated diphenyl ethers (PBDEs) are able to cross
the blood-brain barrier [3] and cause neurological disorders in
developing animal models by affecting learning, memory and
motor functions [4–6]. Therefore, these compounds could also
potentially pose a risk to human health [7]. However, few studies
have been undertaken to investigate whether the currently used
BFRs such as tetrabromobisphenol-A (TBBPA) and hexabromo-
cyclododecane (HBCD) also have neurotoxic effects. Therefore as
an initial step towards investigating this, detailed in-vitro studies
would need to be undertaken.
It is now well documented that many of these chemicals do bio-
accumulate within animals including man [7]. Analysis of human
blood samples has detected relatively high concentrations of some
of these pollutants. For instance DBPE (BDE-209) has been shown
to reach levels of 3100ng/g blood lipid (equivalent to 3mmol/l), in
some blood samples from workers employed in electronic
dismantling facilities [8]. Another study showed HBCD to be as
high as 850ng/g blood lipid (equivalent to 1.3mmol/l) in humans
working in polystyrene manufacture [9]. It is unknown to what
levels these chemicals can reach in human brains, however, animal
studies have shown that they are able to cross the blood brain
barrier [3] and given their high lipophilicity [10] accumulation in
the brain is likely.
Most attention has so far focussed on the potential neurodevel-
opmental effects of BFRs [4–6] rather than their presence as
potential risk factors associated with neurodegenerative diseases.
In this study we therefore focus on the potential cellular disrupting
effects of some commonly used BFRs by assessing their affects on
the viability of SH-SY5Y human neuronal cells, investigating their
mechanisms by which they cause neuronal cell death, and their
ability to produce b-amyloid peptide (Ab), a key pathological
biomarker for neuro-degeneration such as in Alzheimer’s disease.
Materials and Methods
Chemicals
Tetrabromobisphenol-A (TBBPA) (purity of 97%) (Acros
Organics, UK), Hexabromocyclododecane (HBCD) (purity of
95%), and Decabromodiphenyl ether (DBPE) (purity of 97%) were
purchased from Sigma-Aldrich, The amino-methylcoumarin
(AMC) fluorogenic caspase substrate Ac-DEVD-AMC (caspase-
3/7) was purchased from Alexis Biochemicals (UK). The caspase
inhibitor Z-IETD-FMK [11,12] was purchased from Merck
Chemicals Ltd (UK). Dulbecco’s Modified Eagle’s medium
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(DMEM) and foetal bovine serum (FBS) were purchased from
Lonza (UK).
Cell Culture
The SH-SY5Y neuroblastoma cells (from ATCC) were grown
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 2 mM L-glutamine,1% penicillin (20 units/ml), streptomycin
(20 mg/ml), and containing 10% (vol/vol) heat-inactivated foetal
bovine serum (FBS). Cells were maintained at 37uC in a saturated
humidity atmosphere containing 95% air and 5% CO2.
Cell Viability Assay
Cells were seeded in 24-well cell culture plates and allowed to
grow at 37uC until about 70% confluency was reached (typically,
46104 cells/well). Treatment with the chemicals was undertaken
in the culture medium with DMEM (high glucose / without
phenol red or FBS). Stock solutions of the chemicals were
prepared in dimethyl sulfoxide (DMSO) and no more than 1% v/v
was added to the cells. The cells were exposed to varying
concentrations of the chemicals for 24 h and cell viability was
determined by MTT assay as described in [13,14]. Cell viability
with HBCD was also assessed by propidium iodide staining and
FACs analysis as described in [15]. In some cell viability assays the
caspase inhibitor, Z-IETD-FMK (40mM) was used.
Caspase Activity
Caspase-3/7 activity in cell lysates were assayed using the
fluorogenic substrate Ac-DEVD-AMC. SH-SY5Y cells (56105
cells) were incubated in the presence of the chemicals for typically
12h and then lysed in 500 ml of lysis buffer (10 mM Tris–HCl, pH
7.5, 130 mM NaCl, 1% Triton-X- 100, 10 mM Na4P2O7, and
10 mM Na2HPO4), on ice. To 1ml of protease buffer (20 mM
HEPES, 10% glycerol and 2 mM dithiothreitol, pH7.5) was added
20 mM of substrate (final concentration) and 100 ml of the cell
lysate, and the mixture was incubated for 1 h at 37uC. The
fluorescence (due to release of AMC from the peptide) was
measured with a spectrofluorometer set at the excitation
wavelength of 380 nm and emission wavelength of 460 nm and
comparing the values to a standard curve using 7-amino-4-
methylcoumarin.
Cytochrome c Release Assay
Detection of cytochrome c in mitochondrial and cytosolic
protein extracts was undertaken by immunoblotting. SH-SY5Y
cells (56105 were incubated in the presence of compounds
(dissolved in DMSO) in DMEM culture medium for 12 h. The
cells were suspended in lysis buffer (20 mM HEPES, pH 7.5,
containing 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, and 1 mM phenylmethylsulfonyl fluoride),
and disrupted using a Dounce homogenizer. The cell lysates were
centrifuged at 10,000g for 10 min and the supernatants were
further centrifuged at 100,000g for 30 min. Proteins in the final
supernatant (cytosolic fraction) and first centrifuged pellet
(incorporating the mitochondrial fraction) were separated by
15% SDS-PAGE followed by electro blotting onto nitrocellulose
membranes. After blocking and washing, the membrane was then
probed with an anti-cytochrome c antibody (C-20; Santa Cruz
Biotechnology, Inc), at a dilution of 1:500 for 1 h. and cross-
reactivity was detected using secondary antibodies as described in
[16].
Measurement of Mitochondrial Membrane Potential
(MMP)
Mitochondrial membrane potential (MMP) in SH-SY5Y cells
were monitored using the fluorescent dye Rhodamine123 (Rh123)
as described in [13,14].
Detection of Reactive Oxygen Species
Reactive oxygen species (ROS) formation was measured by
using the fluorescent probe 2’,7’-dichlorofluorescein diacetate
(DCFH-DA) which forms 2’,7’-dichlorofluorecein (DCF) when
oxidized by ROS. SH-SY5Y cells were cultured to 70%
confluency in 12-well plates and treated with the compounds for
24 h, and then subsequently washed with PBS and loaded with
40 mM DCFH-DA (added in DMSO) at 37uC with 5% CO2 and
constant humidity for 30 min. At the end of the incubation, the
cells were washed with PBS. 100 ml NaOH (1 M) was added to
extract the fluorescent product from the cells. The fluorescent
intensity of the cell extracts were measured with a Perkin Elmer
LS-50B spectrofluorimeter (excitation 485 nm and emission
530 nm). ROS formation was expressed as the amount of DCF
formed using a DCF standard curve and then compared to control
cell values.
Fluorescence Measurement of Changes in Intracellular
[Ca2+]
SH-SY5Y cells were allowed to grow to 70% confluency on
gelatin-coated coverslips. The coverslips were incubated in sodium
hydrogen carbonate-supplemented HBSS (pH 7.2), which con-
tained 0.08 mM sulfinpyrazone, 1% bovine serum albumin,
0.025% pluronic acid and 10 mM Fluo-3-acetoxymethyl ester
(Fluo-3 AM) for 50 min. This solution was then removed, replaced
with fresh HBSS containing 0.08 mM sulfinpyrazone, and
incubated for an additional 20 min. Each coverslip was then
moved into a 35 mm plastic petri dish containing fresh HBSS
(2 ml final volume), placed onto a heated microscope stage
maintained at 35uC and cells were observed with a Nikon TS100F
microscope in epi-fluorescence mode. The microscope was fitted
with an FITC filter cube so that fluo-3 fluorescence could be
monitored. Recordings of the cells, viewed at about 200x
magnification, were taken using an Astrovid StellaCam3 connect-
ed to a Hauppauge USB TV live video capture device for viewing
on a PC. Win TV (Hauppauge; version 1.4) was used to record
fluorescence images of the cells at a frame rate of 1 frame/s.
Recordings were initiated about 60s before the chemicals were
added, which allowed the initial un-stimulated fluorescence
intensity (Fo) to be determined. All compounds were dissolved in
DMSO cells were exposed to # 1% DMSO in experiments (this
maximum concentration had no effect on the Fluo-3 fluorescence
intensity of cells when added alone). In the case of HBCD, 2-
hydroxypropyl-b-cyclodextrin (150mg/ml) was also added to
improve aqueous solubility. Each series of images were analysed
using Image J software (version 1.32j; National Institutes of Health
USA). For each recording, the analysis involved the measurement
of the mean intensity /cell area for a number of cells. After
corrections for background fluorescence and photo-bleaching were
made, these values were then converted into ratios of fluorescence
intensities with respect to unstimulated fluorescence intensity (F/
Fo) for each cell.
Ca2+ATPase Activity Measurements
Microsomal membranes were isolated from SH-SY5Y cells by
homogenisation and differential centrifugation as previously
described in [16]. Ca2+-ATPase activity (Ca2+-dependent ATP
Neurotoxicity by BFRs
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hydrolysis) from the SH-SY5Y cells was measured using the
phosphate liberation assay as described in [14,16].
Ab-42 –ELISA
Ab 1-42 level was determined by using the BetaMark x-42
ELISA kit (Covance). Cells (56106) were exposed to HBCD,
TBBPA and DBPE for up to 12h. After the desired incubation
times, cell culture supernatants were removed and centrifuged to
remove any cellular debris. Proteinaceous material from the
supernatant was precipitated with 10% trichloroacetic acid (TCA)
for 15 min at 4uC followed by centrifugation at 21,000g. The
resultant pellets were resuspended in a buffer containing 150 mM
Tris- HCl buffer (pH 7.5) containing 150 mM NaCl, 1% Nonidet
P-40, 0.1% sodium dodecyl sulfate, 2 mM EDTA, in presence of
PMSF (1mM) and leupeptin (10mM) and diluted with working
incubation buffer according to the manufacturer’s instructions.
Ab-42 was then detected using an antibody-amyloid-antibody
(sandwich) complex and compared to values gained using a known
amount of Ab-42 peptide as a standard. The experiments were
performed in triplicate.
Statistical Analysis
All data values are expressed as the mean and include standard
deviations (S.D). Statistical significance (p) of selected data,
compared to controls, were analyzed using either Student’s t-test
or the ANOVA multiple comparison test.
Results
Effects of Some BFRs on SH-SY5Y Neuronal Cell Viability
Using the MTT cell viability assay it can be deduced that of the
3 chemicals tested (over a 24 hour exposure), HBCD was the most
potent at inducing cell death in the SH-SY5Y neuroblastoma cells
(figure1). The LC50 for HBCD was calculated to be 2.760.7mM
which was similar to the value observed for HBCD in cerebellar
granule cells [17] and may indicate that a range of neuronal cell
types are similarly affected by this chemical. HBCD (3mM) also
caused an approximately 2-fold increase in the number of non-
viable cells as determined by propidium iodide stained cells and
FACS analysis (Figure 1, inset). The LC50 for TBBPA and DBPE
using the MTT assay were determined to be 1564 mM and
2867 mM, respectively.
Involvement of Caspases
It is unclear whether apoptosis is involved in the cytotoxicity by
some BFRs [17,18]. Apoptosis is executed by caspase 3/7,
activated through two major pathways, intrinsically (involving
the mitochondria and abnormally elevated intracellular [Ca2+]) or
extrinsically (through death receptors) [19]. Figure 2A shows the
effects of different concentrations of HBCD, TBBPA, and DBPE
on caspase-3/7 activity after the cells were exposed to these
chemicals for 12 hours. As can be seen, all three BFRs caused a
significant dose-dependent increase in caspase 3/7 activity over
the concentration ranges tested. The most potent were HBCD and
TBBPA, both showing elevated levels of caspase 3/7 activity
compared to control cells at a 1 to 5mM concentration range.
DBPE at 10mM and above also increased the caspase activity.
There was also a rapid onset of caspase activation since within 4
hours post exposure with HBCD (5mM), caspase 3/7 activity
increased significantly from 0.760.1 to 1.260.1 nmoles AMC
produced/mg/h. In order to determine whether cell death was
through caspases-dependent apoptosis, the level of cell death
caused by of HBCD (2mM) in the presence of the caspase inhibitor
Z-IETD-FMK was measured (figure 2B). The inhibitor afforded
significant protection from cell death, indicating that caspases
were, at least in part, involved in this process.
Involvement of the Mitochondria
In order to determine whether mitochondria are involved in the
cytotoxicity caused by BFRs a number of mitochondrial processes
were studied. Figure 3A shows that DBPE, TBBPA and HBCD
(all applied to the cells at 10mM), induced mitochondrial
depolarisation of the cells within a few seconds of addition, as
assessed by a rapid decrease in rhodamine123 fluorescence of the
cells. Each trace was the average of the fluorescence change
observed for 10 cells analyzed within the field-of-view through the
fluorescence microscope (about 1/3 of the total cells) and was
typical of 3 replicates. When no compound was added only a slow
rate of fluorescence decrease was observed, due to photo-bleaching
[14].
Figure 3B shows the effects of cytochrome c release as assessed
by immuno-blotting analysis of the mitochondrial fractions and
cytosolic fractions obtained from SH-SY5Y cells following
treatment with the BFRs for 12 h. In control cells all the
cytochrome c was detected in the mitochondrial fraction with
none detected in the cytosolic fraction. Cytochrome c, however,
appeared in the cytosol of SH-SY5Y cells after treatment with 5 &
10 mM HBCD, 10 mM TBBPA and 20 mM DBPE.
One consequence of compromised mitochondria is oxidative
stress which generates potentially damaging reactive oxygen
species (ROS). Figure 3C shows the generation of ROS as
monitored by the oxidation of DCF when the cells were exposed to
the chemicals for 24 hours prior to measurements. The figure
shows that HBCD caused a dose-dependent increase in DCF
Figure 1. The effects of hexabromocyclododecane (HBCD) on
SH-SY5Y cell viability. The SH-SY5Y cells were incubated with HBCD
over a range of 0 to 30mM concentration for a period of 24 hours. The
cell viability was then monitored using the MTT assay. The data points
are the mean6S.D. of 4 determinations. (Inset) SH-SY5Y cells were
incubated in the presence or absence of 3mM HBCD for 24 hours, then
labelled with propidium iodide and counted using a fluorescence-
activated cell counter. The percentage values relate to the proportion of
viable (left hand value) and non-viable (right hand value) cells and were
typical of 3 separate experiments.
doi:10.1371/journal.pone.0033059.g001
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fluorescence compared to control cells, with significant levels of
detection above 3mM HBCD. TBBPA also showed significant
levels of ROS increase compared to control cells.
Changes of Intracellular [Ca2+] Levels & Ca2+ ATPase
Activity in SH-SY5Y Cells
Previous studies in this laboratory with TBBPA in testicular cells
have shown that they cause elevation of intracellular [Ca2+] levels
in these cells by inhibiting SERCA Ca2+ pumps [14,20]. From the
literature it is uncertain whether BFRs can also cause changes in
[Ca2+] levels in neuronal cells [17]. Figure 4A shows the effects of
HBCD, TBBPA and DBPE on intracellular [Ca2+] levels using
Fluo-3 AM loaded SH-SY5Y cells. SH-SY5Y cells were exposed to
HBCD at a concentration of 10mM, while TBBPA and DBPE
were used at 20mM. The figure shows traces of the relative
fluorescence changes (indicative of changes in [Ca2+]i) averaged
for 10 individual cells (typical of 3 repeats) viewed, using the
fluorescence microscope, the profiles of which were typical of the
majority of cells observed. The arrow indicates the addition of the
BFRs after around 60s from the start of the recording. The rise in
[Ca2+]i measured as an increase in relative fluorescence attained
maximal levels within about 1min of the addition of the chemicals.
These elevations in intracellular [Ca2+] levels were transient in
nature and returned back towards un-stimulated levels over a 5
min period. Figure 4B shows the dose-dependent effects of HBCD
concentration on peak intracellular [Ca2+] levels within SH-SY5Y
cells as monitored by the maximum level in fluorescence attained.
The concentration required to cause 50% of the maximal increase
in intracellular [Ca2+] levels was calculated to be 961 mM for
HBCD.
The effects of these BFRs were then assessed on microsomal
membranes isolated from SH-SY5Y cells in order to determine
whether they directly inhibited SERCA Ca2+-ATPase activity.
Figure 5 shows that all 3 BFRs tested inhibited the microsomal
Ca2+-ATPase activity from these cells. HBCD appeared to be the
most potent with an inhibition constant Ki of 3.561.2mM. The
inhibition constants determined for TBBPA and DBPE were
962mM and 4167mM, respectively. Figure 5(inset) also shows that
for these BFRs there is a positive trend between their potency of
Ca2+-ATPase inhibition (Ki) and their potency at inducing cell
death (LC50).
BFRs Cause Secretion of b-amyloid Peptide from SH-SY5Y
Cells
There is evidence to link dis-regulation of Ca2+ homeostasis
within neuronal cells and the initiation of neuronal cell
degeneration and cell death which can occur in diseases such as
in Alzheimer’s disease (AD) [21,22]. One of the key molecular
factors in neuronal degeneration is the formation of b-Amyloid
plaques which are known to be neurotoxic [23,24]. b-amyloid
plaques are formed from the aggregation of soluble b-Amyloid
peptides which have been cleaved from the plasma membrane
bound amyloid precursor protein (APP) by the action of c and b
secretase enzymes [23]. In order to determine whether SH-SY5Y
cells treated with BFRs induce the formation and cellular release
of b-amyloid peptide (Ab), the extracellular fluid was analysed and
quantified by sandwich ELISA using a specific b-amyloid-42
antibody. Several Ab peptides can be generated, however, Ab-42
is believed to be the most fibrillogenic and is therefore most closely
associated with AD [24]. Figure 6A shows that HBCD causes an
increase in the extracellular amount of Ab-42 in both a time-
dependent and dose-dependent fashion. Significant levels of Ab-42
peptide were detected, compared to control, in cells exposed for
only 4 hours with HBCD. Figure 6B also shows that concentra-
tions of 3 to 10mM of TBBPA and DBPE, when added to cells for
12 hours also significantly increased the levels of Ab-42 above
those of control cells.
Discussion
Over recent years much attention has been given to the
potentially neurotoxic effects of BFRs particularly in impairment
of neurological development and function [4-6]. These affects may
be due to direct interactions of these compounds with neuronal
cells since animal studies have shown that some BFRs are able to
cross the blood-brain barrier and accumulate within brain tissue
[3]. Several rodent studies have also shown that gestational or
neonatal exposure to environmentally relevant concentrations of
BFRs altered spontaneous behaviour and disrupted habituation in
the adult animal and had profound effects on learning and
memory [4–6].
Figure 2. BFRs increase the activities of caspases in SH-SY5Y
cells. (A) shows the effects of BFRs (TBBPA, HBCD and DBDE) at a range
of concentrations, increase caspase 3/7 activity (using Ac-DEVD-AMC as
the substrate) in SH-SY5Y cells when treated for 12 hours. (B) Shows the
% cell viability of SH-SY5Y cells treated with or without 2mM HBCD and
cells pre-treated with caspase inhibitor Z-IETD-FMK (40mM). (Con) are
cells pre-treated with Z-IETD-FMK but without HBCD. The values
presented are the means6SD of 4 determinations (* and ** indicates
the probability of the values being significant form control data as
determined by t-test with the values having P#0.05 and P#0.01,
respectively). For comparisons of multiple data sets, ANOVA tests of the
probability are given by the P value above the data set lines.
doi:10.1371/journal.pone.0033059.g002
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In-vitro studies have shown that a variety of the BFRs are
cytotoxic and can affect a range of neuronal cell functions, such as
cell signalling processes, neurotransmission and cell death
[17,25,26]. However, little is known of the molecular mechanisms
of these effects.
This study has therefore undertaken an investigation on a
number of BFRs to determine their effects on cultured SH-SY5Y
human neuronal cells. The results presented here show that these
BFRs (and particularly HBCD) are highly cytotoxic, causing cell
death via caspase-dependent apoptosis. The most likely mecha-
nism is that these BFRs activate the intrinsic apoptotic pathway
through exaggerated temporal increases of intracellular [Ca2+]
levels, caused by inhibition of the microsomal Ca2+-ATPase
(SERCA), leading to mitochondria dysfunction which is manifest-
ed as both mitochondrial membrane depolarization and cyto-
chrome c release [13,14,27].
There is substantial evidence to indicate that molecular lesions
associated with AD are caused by dis-regulation of Ca2+ signalling
Figure 3. Effects of BFRs on mitochondrial depolarisation, cytochrome-c release and ROS generation in SH-SY5Y cells. (A) Shows the
effects of DBPE (10mM), TBBPA (10mM), and HBCD (10mM) on mitochondrial membrane depolarisation of SH-SY5Y cells loaded with rhodamine123.
The traces are the averages of 10 individual cells, within the field-of-view and are typical of 3 replicate experiments. The arrow indicates the time
point at which the BFRs were added to the cells. (B) Shows the effects of SH-SY5Y cells (5x105) treated with HBCD (5, 10mM), TBBPA (5mM) and DBPE
(20mM) for 12 hours. The cells were then homogenised and centrifuged to obtain the mitochondrial and cytosolic fractions. The fractions were the
subjected to SDS-PAGE and immuno-stained with an anti-cytochrome c antibody. The blots were typical of two replicate experiments. (C) Shows the
effects of HBCD (1 to15 mM), TBBPA (5mM) and DBPE (5mM) on ROS production as measured by the formation of dichlorofluorescein (DCF). The cells
were treated with the chemicals for 24 hours and then incubated with DCFH-DA for 30 minutes before lysis with NaOH and measuring the DCF
fluorescence. The data represents the mean6SD of 4 determinations (* and ** indicates the probability of the values being significant form control
data of P#0.05 and P#0.01, respectively, using the student’s t-test). For multiple comparison data sets, ANOVA tests were performed (highlighted by
the line) and the P values are given.
doi:10.1371/journal.pone.0033059.g003
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and mitochondrial function [21,22,28]. Some of this evidence has
been generated using cells expressing presenilins (which have been
shown to be mutated in certain forms of genetically induced
familial forms of AD) [21,29,30]. Presenilins form part of the c-
secretase complex which specifically cleaves the C-99 fragment of
APP (,12kDa) to Ab peptide (,4kDa). Mutant presenillins have
also been shown to affect store-operated Ca2+ entry into cells [31],
increase the activity and / or expression of intracellular Ca2+
channels such as the Ryanodine receptor and InsP3 receptor
[29,32–34], and modulate the function of SERCA Ca2+ ATPase
[35]. Furthermore, it is believed that Ab peptides form oligomers
within the plasma membrane of neurons which then cause
excessive Ca2+ influx into the cells [36]. In fact one popular
current idea is that of the ‘ER Ca2+ overload hypothesis’, whereby
ER and other intracellular Ca2+ stores become overfilled with
Ca2+, leading to exaggerated increases in cytosolic [Ca2+] levels
[21,22,36]. Alterations in cytosolic [Ca2+] levels can also be
induced by modulation of Ca2+ re-uptake due to changes in Ca2+-
ATPase expression and or indeed Ca2+-ATPase inhibition [37,38].
Although the effects of excess cytosolic Ca2+ can initially be subtle
and have negligible pathological effects, with increasing age (or
chronic low level toxicological exposure) the Ca2+ homeostatic
machinery is known to become less effective [39], ultimately
leading to Ca2+- induced neuronal cell death.
The observation that micromolar concentrations of HBCD and
TBBPA are able to generate measurable levels of ROS may have
implications for the role of free radical damage to cellular
components such proteins, membranes and DNA. One recent
study using tetrabromodiphenyl ether (PBDE-47) on hippocampal
neuronal cells showed clear evidence of DNA damage at 2mM
using single cell gel electrophoresis ‘comet’ assay, even though an
increase in cell death was not detectable at this concentration [40].
An accumulation of DNA damage over prolonged time periods
caused by low levels of exposure to these types of chemicals could
ultimately also lead to premature neuronal cell death.
We have previously shown that TBBPA is a potent inhibitor of
SERCA Ca2+ pumps in skeletal muscle and testicular cells
[14,20,37]. It now appears that other BFRs also can inhibit
SERCA Ca2+ATPases in neuronal cells. Since a correlation exists
between Ca2+-ATPase inhibition and cell viability for these BFRs,
we postulate that some of these BFRs cause neurotoxicity by
prolonged / exaggerated increases in cytosolic [Ca2+] levels due
modulation of these Ca2+ transporters. There is now an increasing
body of evidence to suggest that abnormally elevated cytosolic
[Ca2+] levels induce a number of potentially neuro-pathological
effects, in-vitro [21,22,28,36,41]. For instance thapsigargin (a
potent SERCA inhibitor) which increases intracellular [Ca2+]
levels has been shown to also increase the expression levels of APP
in some cell types [42], and thapsigargin and other Ca2+ elevating
agents increase levels of Ab peptide in cells expressing APP [43].
Furthermore, elevated [Ca2+] increases the activity of Ca2+-
dependent proteases (calpains) in neuronal cells, which increase
the expression of b-secretase (BACE1) [44]. Activation of caspase
3 (through a Ca2+-dependent mechanism) also increases b-
Figure 4. BFRs cause transient increases in intracellular [Ca2+]
levels in SH-SY5Y cells. (A) Shows the effects of TBBPA (20mM), DBPE
(20mM) and HBCD (10mM) on the transient elevation of intracellular
[Ca2+] levels in SH-SY5Y cells as monitored using Fluo3-AM. The arrow
indicates the point of addition of the chemicals. The changes in relative
fluorescence intensities (F/Fo) are indicative to changes in intracellular
[Ca2+] concentrations and the traces are the averages of 10 individual
cells with the field-of-view. The traces are typical of 3 replicate
experiments. (B) Shows the dose-dependent effects of HBCD on the
maximal (peak) elevation in intracellular [Ca2+] levels (presented as
change in relative fluorescence). The data points are the mean6SD of 3
determinations at each concentration.
doi:10.1371/journal.pone.0033059.g004
Figure 5. BFRs cause SH-SY5Y cell microsomal Ca2+-ATPase
inhibition. The figure shows the effects of HBCD (m), TBBPA (&) and
DBPE (N) on the Ca2+-ATPase activity from microsomes derived from
SH-SY5Y cells measured at pH7.0 and 37uC. The data is presented as the
mean6SD (n = 4). Inset shows the correlation between the inhibition
constants for the BFRs derived from the data in figure 5 with their LC50
values for cell death. From left to right, the points relate to data for
HBCD, TBBPA and DBPE, respectively.
doi:10.1371/journal.pone.0033059.g005
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secretase activity through the degradation of GAA3 an adaptor
protein involved in BACE trafficking [45]. All these Ca2+-
dependent mechanisms are likely to cause increases in Ab peptide
levels within neuronal cells. If these processes were also to occur in
the brain as well as in cultured neurones, then as Ab peptides can
also induce further Ca2+ influx into neighbouring cells [46], this
could lead to a propagating cycle of neuronal cell death
throughout extended regions of the brain.
It is clear from these in-vitro studies that low mM concentrations
of some commonly used BFRs are neurotoxic and amyloidogenic
to cultured neuronal cells. However, in order to determine
whether these compounds might have implications toward
neurodegenerative diseases, animal studies would need to be
undertaken with a view to examining whether pathological signs of
neuro-degeneration are indeed observed after chronic low dose
exposures.
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